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Multiple factors, including members of the FGF, TGFb, and Wnt family of proteins, are important mediators in the regulation
of dorsal–ventral pattern formation during vertebrate development. By using an expression cloning approach to identify novel
factors that could regulate dorsal–ventral patterning in the Xenopus embryo, we isolated the Xenopus homologue of the human
Os4 gene by virtue of its ability to induce a secondary dorsal axis. While Os4 homologues have been identified in a variety of
species, and human Os4 is overexpressed in human tumors, the biological function of Os4 is unknown. To explore the
mechanism by which Xenopus Os4 (XOs4) induces a secondary dorsal axis, we used Xenopus explant and whole-embryo assays.
The secondary axis induced by XOs4 is distinct from that induced by activation of Wnt or FGF pathways but similar to that
induced by inhibition of BMP signaling or activation of an Activin pathway. However, XOs4 did not inhibit BMP signaling in
dissociated animal cap explants, indicating that XOs4 does not inhibit BMP signaling. Similar to activation of an Activin-like
pathway, expression of XOs4 induces molecular markers for mesoderm in animal cap explants, although expression of
gastrula-stage mesodermal markers was very weak and substantially delayed. Yet, XOs4 does not require activity of the Activin
signal-transduction pathway for mesoderm induction as dominant-negative components of the Activin/Nodal/Vg1 pathway did
not prevent XOs4-mediated induction of mesodermal derivatives. Finally, like Activin/Nodal/Vg1 pathways, XOs4 requires FGF
signaling for expression of mesoderm markers. Results presented in this study demonstrate that XOs4 can induce mesoderm and
dorsalize ventral mesoderm resulting in ectopic dorsal axis formation, suggesting a role for this large evolutionarily conserved
gene family in early development. © 2001 Academic Press
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The elucidation of the molecular mechanisms regulating
establishment of the vertebrate body axis has been a subject
of extensive research. By using the Xenopus laevis develop-
mental model system, many groups have focused on the
events that lead to induction and patterning of the early
embryonic axis. In particular, the mechanism of induction
and patterning of the dorsal mesodermal derivatives has
received significant attention. Mesoderm induction occurs
through interactions between the vegetal and animal re-
gions of the embryo (reviewed in Harland and Gerhart,
1997). Establishment of the dorsal–ventral axis is initiated
shortly after fertilization, when cortical rotation results in
1 To whom correspondence should be addressed. Fax: (212) 327-
X8685. E-mail: brvnlou@rockefeller.edu.
118he localization of dorsal determinants to the dorsal–vegetal
egion of the embryo (reviewed in Harland and Gerhart,
997). These dorsal determinants are components of the
nt signal transduction pathway and are involved in in-
uction of a Nieuwkoop center. By late blastula stages,
nteraction of the Nieuwkoop center with cells in the dorsal
arginal zone results in the establishment of the Spe-
ann’s Organizer. The Organizer patterns the embryo
long the dorsal–ventral axis, dorsalizing ventral mesoderm
nd ectoderm. Furthermore, the organizer can induce a
econdary dorsal axis when transplanted to the ventral
egion of the embryo (reviewed in Elinson and Holowacz,
995). The molecular signals that mediate the dorsalizing
ehavior of the organizer have recently begun to be eluci-
ated. Many of the secreted factors originating from the
rganizer (e.g., Chordin, Noggin, Follistatin, Cerberus, and
nr3) act to inhibit BMP signaling in the mesoderm and
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119Expression Cloning of Xenopus Os4ectoderm resulting in dorsalization of mesoderm and neural
tissue, respectively (reviewed in Harland, 2000; Kimelman
and Griffin, 2000; Weinstein and Hemmati-Brivanlou,
1999). Furthermore, Nodal-related TGFb family members
are expressed in the organizer and have the ability to
dorsalize ventral mesoderm (Jones et al., 1995; Joseph and
Melton, 1997; Smith et al., 1995).
TGFb family members activate a signal transduction
cascade resulting in changes in gene transcription (reviewed
in Massague, 1998). Extracellular ligands bind to Type II
receptors that phosphorylate and activate the Type I recep-
tors. Receptor Smads (e.g., Smad2 and -3 in the case of
Activin/Nodal/Vg1 and Smad1, -5, and -9 in the case of
BMP) are then recruited and phosphorylated by the acti-
vated Type I receptor. Upon phosphorylation, the receptor
Smad associates with a common Smad (Smad4), and the
complex is translocated to the nucleus where it associates
with transcription factors (e.g., FAST1 for Activin/Nodal/
Vg1 and OAZ for BMP) to regulate transcription. In addi-
tion, the inhibitory Smads, Smad6 and Smad7, block acti-
vation of TGFb pathways by blocking receptor-induced
hosphorylation of receptor Smads (Ishisaki et al., 1999;
ouchelnytskyi et al., 1998), whereas Smad6 also blocks
mad4 from interacting with Smad1 (Hata et al., 1998).
Experiments where naive ectodermal explants are exposed
o various extracellular ligands have demonstrated that mem-
ers of the TGFb family of ligands such as Activin, Nodal-
elated family members, and Vg1 (Activin/Nodal/Vg1) can
imic the mesodermal-inducing activities of the vegetal cells
reviewed in Whitman, 1998). These types of experiments
ave also demonstrated a role for FGF family members in the
aintenance of mesodermal cell fates (Isaacs et al., 1994;
chulte-Merker and Smith, 1995). Furthermore, FGF ligands
re more likely involved in specifying ventral–posterior me-
oderm rather than dorsal cell fates as observed with Activin/
odal/Vg1 ligands (reviewed in Isaacs, 1997). TGFb family of
ligands act as morphogens, specifying multiple tissue types as
a response to different concentrations of ligand. For example,
incubation of ectodermal explants with Activin results in
induction of lateral mesoderm at low doses and more dorsal
mesoderm at higher doses (Gurdon et al., 1994, 1996; and see
McDowell and Gurdon, 1999 for review). TGFb members in
he BMP subfamily, on the other hand, have ventralizing
ffects in the embryo (reviewed in Dale and Jones, 1999; Dale
nd Wardle, 1999). BMPs will ventralize the ectoderm to adopt
n epidermal rather than neural fate, and the mesoderm to
dopt a ventral rather than dorsal mesodermal fate (reviewed
n Harland, 1994; Weinstein and Hemmati-Brivanlou, 1997;
ilson and Hemmati-Brivanlou, 1997). Finally, dorsalization
f the ventral mesoderm by either activation of Activin/
odal/Vg1 or inhibition of BMP signaling results in dorsal
esoderm formation and induction of a secondary dorsal axis
ontaining trunk but no head structures (reviewed in Lemaire
nd Kodjabachian, 1996).
In an attempt to isolate novel factors that can regulate
mbryonic patterning along the dorsal–ventral axis, we
sed an expression cloning approach. Novel molecules were a
Copyright © 2001 by Academic Press. All rightsolated from a gastrula stage expression library that could
nduce a secondary dorsal axis when expressed in ventral
esoderm. From this screen, the Xenopus homologue of
he human Os4 gene (XOs4) was isolated. The human Os4
ene was originally isolated from a region of chromosome
2q13–q15, which is frequently amplified in human tumors
Su et al., 1997). Additionally, Os4 homologues have been
dentified in numerous species as a result of genome-
equencing projects. However, the function of this large
ene family remains unknown. Our results suggest that,
ike Activin/Nodal/Vg1, XOs4 induces mesoderm in ani-
al cap explants and induces dorsal axis that lack anterior
tructures. However, dominant-negative components in the
ctivin signal-transduction pathway did not prevent induc-
ion of mesoderm in animal cap explants, suggesting that
Os4 may activate pathways resulting in mesoderm induc-
ion either downstream from the Activin/Nodal/Vg1 path-
ays or independent of these pathways.
MATERIALS AND METHODS
Embryo Manipulations
Xenopus embryos were obtained by in vitro fertilization and
staged according to Nieuwkoop and Faber (1967). Microinjections
and dissections were performed as described (Brivanlou and Har-
land, 1989). Briefly, for animal cap assays, Xenopus embryos were
injected at the two-cell stage with the indicated amounts of capped
RNA. Animal cap explants were isolated at the blastula stage and
cultured in 0.53 MMR until the indicated stage. Cell dissociation
assays were performed as described (Wilson and Melton, 1994).
Briefly, animal caps were incubated in Ca21/Mg21-free medium,
reaggregated after 4 h of dispersal and cultured until control sibling
embryos reached late neurula stages.
Construction of Plasmids
Construction of the Xenopus gastrula stage cDNA library was
described previously (Weinstein et al., 1998). pCs2-H4 was the
full-length cDNA isolated from the screen. pCs2-XOs4 (ORF),
pCs2-FLAG-XOs4 was generated by PCR using the following
primers and ligated into the EcoRI/SalI site of pCs2. U(ORF):
59-CGC GGA ATT CCG CCA TGG AAA GCA GCT CTA TAA
TCG CC-39; U(FLAG): 59-CGC GGA ATT CCG CCA TGG ACT
ACA AGG ACG ACG ATG ACA ACC TTG AAA GCA GCT CTA
TAA TCG CC-39; D: 59-CGC GAT GTC GAC TCA TCA AGG
GGC CTT CAG CTG CCC-39). pCs2-XOs4 (1–920) and pBS-XOs4
(920–2335) were generated by subcloning the SalI/XbaI fragment
and the XbaI fragment from pCs2-H4 into pCs2 (Baker and Har-
land, 1996; Turner and Weintraub, 1994) and pBS (Invitrogen),
respectively. The Xwnt-8, tAR, Smad2, Smad7, FLAG-Ldb1,
pCMV-FLAG-DPC4, pCMV-ActRIB(T-D), XFR, Ras(17N), and
v-HA-Ras constructs have been described previously (Agulnick et
al., 1996; Amaya et al., 1991; Casellas and Brivanlou, 1998;
Hemmati-Brivanlou and Melton, 1992; Lagna et al., 1996, 1999;
Whitman and Melton, 1992). A3 and Gsc-Luc plasmids have been
described elsewhere (Huang et al., 1995; Watabe et al., 1995).
Recombinant human BMP-2 was obtained from R&D Systems and
bFGF from Boehringer Mannheim. Activinbb proteins were gener-
ted in oocytes as described (Chang et al., 1997).
s of reproduction in any form reserved.
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120 Zohn and H. BrivanlouFIG. 1. (A) Characterization of the secondary axis induced by ventral expression of XOs4. (a) XOs4 induces a secondary dorsal axis when
njected into the ventral–marginal zone of four- to eight-cell stage embryos. (b) Transverse section of embryo probed with a neural-specific
ntibody (6F-11). (c) Transverse section of an embryo probed with somite-specific (12/101) antibodies. (B) Nucleotide and predicted amino
cid sequence of XOs4. Conserved domain is underlined in red. Conserved phosphatase motif is boxed in blue.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
121Expression Cloning of Xenopus Os4Whole-Mount in Situ Hybridization, Antibody
Staining, and Lineage Tracing
Xenopus embryos were fixed at the indicated stages in MEMFA
and whole-mount in situ hybridization was performed as described
(Harland, 1991) by using BM purple (Boehringer Mannheim) as the
substrate for the chromogenic reaction. XOs4 antisense probe was
synthesized following linearization of the following constructs
with the indicated restriction enzymes and transcribed by using the
indicated promoters: pCs2-H4 (Sal1/T3), pCs2-XOs4 (1–920) (Sal1/
T3), pBS-XOs4 (920–2335) (EcoRI/T7), and pCs2-XOs4(ORF)
(EcoRI/T3). All four in situ probes revealed identical expression
patterns for XOs4. b-Galactosidase (bGal) staining was carried out
as described (Smith and Harland, 1991). Whole-mount antibody
staining was performed as described by Brivanlou and Harland
(1989). The antibodies used were: 12/101 (1:500) for muscle (Kint-
ner and Brockes, 1984); Tor70.1 (1:500) for notochord (Bolce et al.,
1992) anti-FLAG antibody (Sigma) and the neural antigen-specific
antibody 6F11 (1:1) from hybridoma-conditioned medium (NIH). A
goat anti-mouse horseradish peroxidase (1:500; Jackson Laborato-
FIG. 2. (A) Expression of XOs4 gene during early Xenopus em-
bryogenesis. Expression of XOs4 was detected by RT-PCR. ODC is
a ubiquitously expressed gene and represents a loading control.
XOs4 is expressed maternally and expression continues through
tadpole stage. The cDNA clone encoding XOs4 was used in the last
lane as a positive control. (B) XOs4 is ubiquitously expressed at
gastrula stage. Stage-101 embryos were dissected as diagrammed
into dorsal marginal zone (D), ventral–marginal zone (V), animal
pole (AN), and vegetal pole (VG) explants and subjected to RT-PCR
analysis using primers that amplify XOs4 and various markers to
control for proper dissection of explants.ries) was used as a secondary antibody. After staining, embryos
Copyright © 2001 by Academic Press. All rightwere refixed in MEMFA and embedded in 20% gelatin in PBS.
Embedded embryos were refixed in 4% paraformaldehyde in PBS
and sectioned (50- to 100-mm sections) by using a vibratome.
Sections were cleared in 90% glycerol before being photographed.
RT-PCR Assay
The RT-PCR analysis of gene expression was performed as
previously described (Chang et al., 1997). The primers used were:
XOs4 (U: 59-GAT GGA AAG CAG CTC TAT AAT CG-39; D:
59-GGC TGA CAT TCT GTG CAT TGA GGC-39); ODC (Bassez et
al., 1990); Vg1 (Weinstein et al., 1996); Wnt8 (Smith and Harland,
1991); XBra (Smith et al., 1991); Xnr3 (Smith et al., 1995); Sia
(Lemaire et al., 1995); NCAM (Kintner and Melton, 1987); EK
(Jonas et al., 1985); XAG (Blitz and Cho, 1995); Col.II (Su et al.,
1991); CA (Stutz and Spohr, 1986); HoxB9/XIHBox-6 (Wright et al.,
1990); EF1a (Krieg et al., 1989); Twist (Chang and Hemmati-
Brivanlou, 1998); Chd (Sasai et al., 1994), Lim1 (U: 59-CCG CCC
ATT CCT CTA AAA TCC C-39; D: 59-GGA GAT AAA CTG GGG
TCA CTG CC-39, Xeomes (U: 59-TGC GGC AAA GCG GAC AAC
AAT A-39; D: 59-TCT CCG GGA AGG TAA AGG TCT GG-39.
Cellular Localization in Cos1 Cells
Cos1 cells were transfected with the pCs2-FLAG-XOs4 or
pCMV-FLAG-DPC4 plus activated Activin receptor (pCMV-
ActRIB(T-D) by using lipofectamine according to the manufactur-
er’s instructions. Thirty-six hours following transfection, cells
were trypinsized and plated onto sterile coverslips. Forty-eight
hours after transfection, cells were fixed in 4% paraformaldehyde
and incubated overnight in blocking solution (PBS with 1% Triton
X-100 and 3% BSA). Coverslips were incubated in blocking solu-
tion supplemented with anti-FLAG antibody (Sigma) for 1 h at
room temperature (1:1000 dilution), followed by incubation in
FITC-conjugated anti-mouse antibody (Jackson Laboratories) and
treated with Vectashield (Vector Laboratories).
Luciferase Assays
Embryos were injected at the eight-cell stage in one animal
blastomere with 1 ng of RNA encoding Smad2 or XOs4 and 100 pg
of either A3-Luc or Gsc-Luc plasmids (Huang et al., 1995; Watabe
et al., 1995). At stage 11.5, embryos were lysed and luciferase
activity was measured by using Dual-Luciferase Reporter Assay
system (Promega).
RESULTS
Cloning and Characterization of XOs4
To identify novel molecules involved in patterning of the
vertebrate body axis, we used an expression cloning ap-
proach to identify factors that could induce a secondary
dorsal axis when expressed in the ventral marginal zone of
Xenopus embryos. For this screen, pools of 100 RNAs
synthesized from a gastrula-stage cDNA library were in-
jected in the ventral–marginal zone of eight-cell stage
Xenopus embryos. Embryos were allowed to develop until
tadpole stage, when secondary axis induction was exam-
ined. Individual clones that possessed secondary axis-
s of reproduction in any form reserved.
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122 Zohn and H. Brivanlouinducing activity were isolated by sib selection (Smith and
Harland, 1991, 1992). We identified a single clone that,
when injected at 0.5–4 ng of RNA per embryo, induced
secondary axis formation in 62% of embryos (n 5 130; Fig.
1A-a). The secondary axis was incomplete and lacked head
structures (Fig. 1A-a). Histological analysis showed that the
secondary axis contained dorsal mesoderm derivatives in-
cluding muscle (Fig. 1A-c), as well as neural tissue (Fig.
1A-b), and sometimes notochord (data not shown).
Sequence analysis revealed that the 3.5-kb insert con-
tained an 816-bp open reading frame (ORF) encoding a
putative 271-amino acid protein (Fig. 1B) with a predicted
molecular weight of 30 kDa, which was confirmed by
SDS–PAGE analysis (data not shown). Expression in the
ventral marginal zone of 100 pg RNA synthesized from the
predicted ORF resulted in induction of secondary dorsal
axis, and this XOs4 (ORF) construct was used for further
analysis. Sequence comparison with the databases revealed
that the ORF corresponds to the Xenopus homologue of the
human Os4 gene (Su et al., 1997). Although no embryologi-
cal activity has been assigned to the Os4 gene family,
human Os4 (hOs4) was originally identified in a region of
chromosome 12q13–q15, which is frequently amplified in
human sarcomas and brain tumors (Su et al., 1997). Another
closely related family member, HYA22, is localized to
human chromosome 3p22-21.3, which is frequently deleted
in carcinomas of the lung, kidney, and other human tumors
(Ishikawa et al., 1997). Furthermore, genome-sequencing
projects have identified Os4-related proteins in eukaryote
species as divergent as Dictyostelium, Oryza sativa (rice),
Arabidopsis, Schizosaccharomyces pombe, Saccharomyces
cerevisae, Caenorhabditis elegans, Drosophila melano-
gaster, and Homo sapiens. Alignment of XOs4 with Os4
family members from a variety of species reveals a highly
conserved domain of approximately 185 amino acids (un-
derlined in Fig. 1B), which contains the conserved phospha-
tase DXDXT/V motif (boxed in Fig. 1B). No other motifs
were detected that would suggest the function of XOs4.
XOs4 Transcripts Are Expressed throughout Early
Xenopus Development
RT-PCR analysis using primers specific for XOs4 cDNA
revealed that XOs4 was expressed maternally and expres-
sion continued through gastrula, neurula, and tadpole
stages (Fig. 2A). At gastrula stage, XOs4 was expressed in
dorsal, ventral, animal, and vegetal regions of the embryo
(Fig. 2B). In situ hybridization analysis revealed high levels
of XOs4 expression in the ectoderm and lower levels in the
preinvoluting mesoderm in early gastrula stage (101) em-
ryos (Fig. 3A-a, and data not shown). At neurula stage,
xpression became enriched in the neural plate with lower
evels observed in the epidermis (Fig. 3A-b). In tailbud- stage
20) embryos, high levels of XOs4 expression were detected
n the skin and neural crest cell derivatives. Tadpole-stage
mbryos (Stage 28) exhibited high levels of XOs4 transcripts
n the dorsal neural tube, including the roof plate and neural
Copyright © 2001 by Academic Press. All rightrest (Fig. 3A-c). Expression of XOs4 transcripts continued
n the epidermis and became enriched in the developing
ronephros, the head, and neural crest cell derivatives,
ncluding the cephalic and trunk neural crest. XOs4 tran-
cripts were also highly expressed in the eye and otic
essicle (Fig. 3A-d).
XOs4 Protein Is Present in the Nucleus and
Cytoplasm
In order to determine the subcellular localization of
XOs4, a FLAG epitope-tagged XOs4 construct was used.
RNA encoding FLAG-XOs4 was equally efficient at induc-
ing secondary axis formation as the untagged version when
injected into the ventral marginal zone of eight-cell stage
embryos (data not shown), indicating that addition of the
epitope tag does not interfere with the function of the
protein. RNA encoding FLAG-XOs4 was injected into two-
cell stage embryos. Embryos were fixed at gastrula stage and
expression of the FLAG-XOs4 fusion protein was detected
by whole-mount immunocytochemistry with an anti-
FLAG antibody. Visualization of FLAG staining revealed
FLAG-XOs4 protein was localized to the cytoplasm and the
plasma membrane regions of the cell (Fig. 3B-b). FLAG-
XOs4 also exhibited staining typical of nuclear localized
proteins, such as Ldb1 (Fig. 3B-a). A similar expression
pattern was observed in Cos cells (Fig. 3B-d), where XOs4
protein was detected in the cytoplasm and higher levels in
the nucleus.
XOs4 Induced a Secondary Axis Similar to That
Induced by Activation of the Activin/Nodal/Vg1
Pathway or Inhibition of the BMP Pathway
In order to characterize the mechanism of secondary axis
induction by XOs4, the morphology of XOs4-induced sec-
ondary axis was compared with secondary axis induced by
other pathways. For these experiments, RNA encoding
v-Ras (FGF signaling), Wnt-8, Smad-2 (Activin/Nodal/VG1
signaling), Smad7 (inhibition of BMP signaling), or XOs4
were injected into the ventral marginal zone of eight-cell
stage embryos. Embryos were allowed to develop until
tadpole stage where the morphology of the secondary axis
was observed. Activation of the FGF pathway by expression
of activated v-Ras (Fig. 4A-b), FGF, or laloo (Ruiz i Altaba
and Melton, 1989; Weinstein et al., 1998; Whitman and
Melton, 1992) in the ventral marginal zone resulted in
induction of ectopic tail-like rather than trunk-like struc-
tures. Activation of the Wnt pathway by expression in the
ventral marginal zone of Wnt-8 resulted in ectopic dorsal
axis that contained trunk structures with heads, cement
glands, and eyes (Fig. 4A-c) (Sokol et al., 1991). In contrast,
activation of the Activin/Nodal/Vg1 pathway by expression
of Smad2 (Fig. 4A-e) or inhibition of BMP signaling by
expression of Smad7 (Fig. 4A-d) resulted in induction of
secondary axis that was morphologically indistinguishable
from those induced by XOs4 (Fig. 4A-f). The secondary axis
s of reproduction in any form reserved.
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123Expression Cloning of Xenopus Os4induced by Smad2, Smad7, and XOs4 contained trunk
structures that lack heads, cement glands, or eyes. There-
fore, the secondary axis induced by XOs4 is similar to that
observed by activation of the Activin/Nodal/Vg1 pathway
or inhibition of BMP signaling rather than activation of FGF
or Wnt pathways. However, since low levels of Wnt path-
way activation can induce secondary axis that lack head
structures, the ability of XOs4 to activate the Wnt pathway
was examined in more detail.
Activation of the Wnt signal-transduction pathway re-
sults in induction of a Nieuwkoop center. In order to
determine whether XOs4 induces a Nieuwkoop center,
lineage-tracing analysis was done to follow the fate of
XOs4-injected cells. For these experiments, a D-teir ventral-
vegetal blastomere of a 32-cell stage embryo (Fig. 4B) was
coinjected with RNA encoding either: XOs4, Smad7,
Smad2, or XWnt8 with bGal as a lineage tracer. Based on
ate map analysis (Dale and Slack, 1987), this blastomere
ill primarily contribute to the endoderm (Figs. 4C-a and
C-e). When coinjected with RNA encoding Wnt8, the
bGal-expressing cells were not incorporated into the sec-
ondary axis but remained in the endoderm (Figs. 4C-b and
4C-f). In contrast, inhibition of TGFb signaling (Smad7) or
ctivation of the Activin/Nodal/Vg1 pathway (Smad2) (Figs.
C-c and 4C-g, and data not shown) resulted in bGal-
injected cells being incorporated into the secondary axis
(Baker and Harland, 1996; Casellas and Brivanlou, 1998).
Similar to overexpression of Smad7 or Smad2, injection of
RNA encoding XOs4 resulted in localization of the bGal-
xpressing tissue to the secondary axis (Figs. 4C-d and
C-h).
To further exclude activation of the Wnt pathway, the
bility of XOs4 to induce expression of Wnt-responsive
enes in an animal cap assay was determined. Expression of
nt8 in the animal cap results in the induction of the
olecular markers Xnr3 and Sia (Lemaire et al., 1995;
mith et al., 1995). In contrast, XOs4 failed to induce
xpression of Xnr3 or Sia (Fig. 4D), suggesting that XOs4
oes not activate a Wnt8-like pathway. Taken together,
hese results suggest that it is unlikely that XOs4 induces a
econdary axis by activation of Wnt or FGF pathways.
XOs4 Induces a Secondary Axis by Induction of
Dorsal Mesoderm Rather Than Inhibition of
BMP Signaling
Similar to inhibition of BMP signaling (Smad7, data not
shown), or activation of the Activin/Nodal/Vg1 pathway
(Smad2, Fig. 5A), expression of XOs4 in ventral mesoderm
explants resulted in expression of dorsal mesodermal mark-
ers, such as Cardiac actin and Collagen II, when sibling
control embryos reached tadpole stage (Fig. 5A). While both
Smad7 and Smad2 dorsalize ventral marginal zone explants
in this assay, they utilize different mechanisms. Activation
of the Activin/Nodal/Vg1 pathway results in induction of
mesoderm of a dorsal character, whereas inhibition of the
ventralizing BMP signals results in dorsalization of ventral
Copyright © 2001 by Academic Press. All rightesoderm. In order to determine whether XOs4 inhibits
MP signaling, the ability of XOs4 to block the epidermal-
nducing activity of BMP was assayed in dissociated animal
ap cells. When animal cap explants are dissociated, endog-
nous BMP is diluted and, by default, neural tissue is
nduced (Hemmati-Brivanlou and Melton, 1992, 1994). Ad-
ition of BMP induces an epidermal cell fate as demon-
trated by the induction of Epidermal Keratin (Wilson and
emmati-Brivanlou, 1995). Expression of BMP inhibitors
uch as Smad7 blocks the ability of exogenous BMP to
nduce epidermal ectoderm in dissociated explants, result-
ng in neural induction (Casellas and Brivanlou, 1998). In
his assay, we found that expression of XOs4 in dissociated
nimal caps did not inhibit BMP-mediated epidermal induc-
ion (Fig. 5B), suggesting that XOs4 does not inhibit the
MP signaling pathway.
Activation of Activin/Nodal/Vg1 signaling and inhibition
f BMP signaling can further be distinguished by molecular
arker analysis by using an animal cap assay. Activin/Vg1/
odal causes mesoderm induction and secondary neural
nduction in animal cap explants (Chang et al., 1997). In
ontrast, inhibition of endogenous BMP activity results in
he induction of neural fate without induction of mesoderm
Suzuki et al., 1997; Wilson and Hemmati-Brivanlou, 1995).
To further elucidate the mechanism of secondary axis
induction by XOs4, the ability of XOs4 to induce neural and
mesodermal markers in animal cap explants was assayed.
For these experiments, RNA encoding XOs4 was injected
into the animal pole region of two-cell stage embryos and
animal cap explants were dissected at blastula stage. Ani-
mal cap explants were assayed by RT-PCR for expression of
neural and mesodermal markers at tadpole stage. XOs4-
expressing animal caps exhibited a slightly elongated mor-
phology (Fig. 6A). Upon examination of molecular markers
at tadpole stage (Fig. 6B), XOs4 was found to induce expres-
sion of molecular markers for neural tissue and dorsal and
lateral mesoderm. XOs4 induced expression of: Cardiac
actin and Collagen II (dorsal mesodermal); HoxB9 (posterior
lateral mesodermal and posterior spinal chord); Twist (lat-
eral mesoderm and neural crest), NCAM (neural), and XAG
(cement gland). These results further suggest that XOs4
induces a secondary axis in a manner similar to Smad2
rather than Smad7, since, like Smad2, XOs4 induces expres-
sion of molecular markers for dorsal and lateral mesoderm.
Furthermore, since XOs4 did not inhibit BMP signaling in
dissociated ectoderm explants, the neural tissue induced is
likely due to secondary neural induction.
Activin/Nodal/Vg1 pathways induce expression of meso-
dermal markers in gastrula-stage animal cap explants. To
further investigate the possibility that XOs4 activates the
Activin/Nodal/Vg1-like pathway, the ability of XOs4 to
induce mesoderm in gastrula-stage explants was assayed.
For these experiments, Smad2- or XOs4-expressing animal
cap explants were examined for expression of the pan-
mesoderm markers XBra and Xeomes. XOs4 very weakly
induced expression of Xeomes but not XBra in early
gastrula-stage (10.5) animal caps (Fig. 7A). Since expression
s of reproduction in any form reserved.
o
m
d in
o the
124 Zohn and H. Brivanlouof Xeomes transcripts are detected before XBra at Stage 9
rather than Stage 10 in Xenopus embryos (Ryan et al., 1996),
FIG. 3. (A) Spatial expression pattern of XOs4 in Xenopus embry
dorsal blastopore lip. (b) Dorsal view of a Stage-15 embryo; anterior
staining in dorsal neural tube and neural crest. (d) Lateral view of a
nc, neural crest; nt, neural tube; nc, notochord; ey, eye; ov, otic ves
of XOs4. (b) Ectopically expressed Flag-tagged XOs4 is localized in S
and exhibits staining characteristic of nuclear localization. (a) FLA
(d) XOs4 is localized to the cytoplasm and nucleus when expresse
Activin receptor (pCMV-ActRIB(T-D), FLAG-Smad4, is localized tthis raises the possibility that XOs4 is delayed in induction s
Copyright © 2001 by Academic Press. All rightf mesoderm. Therefore, expression of early mesoderm
arkers was examined at later time points. At late gastrula
a) Vegetal view of a Stage-101 embryo; dorsal is up; arrows mark
the left. (c) Transverse section of a Stage-28 embryo demonstrating
-32 embryo; anterior is to the left. np, neural plate; epi, epidermis;
; ba, branchial arches; pn, pronephros. (B) Intracellular localization
101 Xenopus embryos to the cytoplasm and the plasma membrane
b1 is localized to the nucleus and exhibits characteristic staining.
Cos-1 cells. (c) pCMV-FLAG-DPC4 coexpressed with an activated
nucleus in Cos-1 cells.os. (
is to
Stage
sicle
tage-
G-ldtage (12), XOs4 very weakly induced expression of the
s of reproduction in any form reserved.
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125Expression Cloning of Xenopus Os4FIG. 4. (A) XOs4 induces a secondary axis distinct from that induced by activation of FGF or Wnt pathways but similar to activation of
ctivin or inhibition of BMP pathways. Uninjected (2) or RNA encoding v-Ras (25 pg, b), Wnt-8 (20 pg, c), Smad7 (100 pg, d), Smad2 (1 ng,
), or XOs4 (100 pg, f) was injected into the ventral marginal zone of eight-cell stage embryos. Embryos were allowed to develop until tadpole
tage where the induced secondary axis was observed. (B, C) Lineage-tracing analysis reveals that XOs4 does not remain in the endoderm
ut participates in the formation of the secondary axis. One D-teir ventral–vegetal cell (B) of a 32-cell stage embryo was coinjected with
NA encoding bGal (C-a and C-e) or combined with RNA encoding Wnt8 (C-b and C-f), Smad7 (C-c and C-g), or XOs4 (C-d and C-h). (D)
Os4 is not able to induce the Wnt-responsive markers Xnr3 and Sia. The indicated amounts of RNA were injected into the animal poleegions of two-cell stage embryos and ectodermal explants were processed for RT-PCR analysis as described in Materials and Methods.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
126 Zohn and H. Brivanloupan-mesoderm markers Xeomes and XBra and the ventral–
lateral mesoderm marker Wnt-8 (Fig. 7B). In addition,
unlike Smad2, XOs4 did not induce significant expression
levels of organizer-specific markers such as Chordin and
Lim-1.
To further address the possibility that XOs4 activates the
Activin pathway, we assayed the ability of XOs4 to stimu-
late transcription from Activin-Responsive-Elements
(AREs). The ability of XOs4 to activate transcription from
the Gsc promoter and the ARE from the Mix.2 promoter
were assayed by using Luciferase reporter constructs. Coin-
jection of XOs4 with the Gsc or Mix.2 transcriptional
reporter constructs in one animal blastomere of eight-cell
stage embryos resulted in little or no activation of the
reporter gene construct as compared with Smad2 control
injections at late gastrula stage (Fold activation of Gsc-Luc:
control, 1 6 0.28; Smad2, 13.6 6 2.3; XOs4, 1.4 6 0.1. Fold
activation of A3-Luc: control, 1 6 0.8; Smad2, 27.1 6 5.7;
FIG. 5. (A) XOs4 dorsalizes ventral–marginal zone explants. Four-
cell stage embryos were injected in the marginal zone region in all
four blastomeres with RNA (1 ng/embryo) encoding XOs4 or
Smad2. Ventral or dorsal marginal zone explants were dissected at
Stage 101 and cultured until sibling control embryos reached
tailbud stage (Stage 28). (B) XOs4 does not inhibit BMP signaling.
Uninjected animal caps or animal caps expressing XOs4 (1 ng) were
dissociated at late blastula stage and cultured in the presence or
absence of BMP (10 ng/ml). At the end of neurulation, cells were
reaggregated and cultured until control embryos reached late
neurula stage (Stage 15) and processed for RT-PCR analysis for
molecular markers for neural and epidermal tissue.XOs4, 1.5 6 0.5. Data representative of three separate
Copyright © 2001 by Academic Press. All rightexperiments preformed in triplicate.). These results suggest
that XOs4 may not activate the Activin/Nodal/Vg1 path-
way.
Induction of Mesodermal Derivatives by XOs4
Does Not Require Activity of the Activin Signal-
Transduction Pathway
To determine whether XOs4 requires activity of the
Activin/Nodal/Vg1 pathway for induction of mesodermal
derivatives, dominant-negative components of this path-
way were coexpressed with XOs4 and the ability of these
reagents to block XOs4-induced mesoderm was assayed. We
first examined whether XOs4 required the activity of the
Activin receptor to induce HoxB9 expression in tadpole-
stage (28) animal cap explants, since XOs4 induces expres-
sion of HoxB9 at lower doses than more dorsal mesodermal
markers such as Cardiac actin and Collagen Type II. For
these experiments, XOs4 was coexpressed with a dominant-
negative type II Activin receptor (tAR/DN-ActRIIB). While
expression of tAR blocked induction of HoxB9 by Activin,
expression of the tAR did not block XOs4 (Fig. 8A). Simi-
larly, FAST1-EnR essentially eliminated induction of
HoxB9 by Activin. In contrast, XOs4 was still able to induce
HoxB9 expression in the presence of FAST1-EnR, suggest-
ing that while the mesoderm-inducing activity of Activin is
absolutely dependent on FAST1 activity, the mesoderm-
inducing activity of XOs4 is, in part, FAST-independent.
These results support the hypothesis that XOs4 may acti-
vate pathways either downstream from the Activin path-
way, or independent of this pathway resulting in mesoderm
induction.
Interestingly, like induction of mesoderm by Activin/
Nodal/Vg1 pathway, induction of mesoderm by XOs4 was
also dependent on FGF signaling. Coexpression of XOs4
with either the truncated FGF receptor (XFR) or dominant-
negative Ras (Ras17N) resulted in inhibition of HoxB9
induction in tadpole (Stage 28)-stage animal cap (Fig. 8B).
This was similar to the inhibition observed when Activin or
Smad2 were coexpressed with these inhibitors (Fig. 8B, and
Cornell and Kimelman, 1994; LaBonne and Whitman,
1994). These experiments cannot rule out a requirement for
FGF signaling in the initial induction of mesoderm by
XOs4. However, the observation that XOs4 induces a sec-
ondary axis distinct from that induced by activation of the
FGF pathway (Fig. 4A), suggests that it is unlikely that
XOs4 primarily activates this pathway for induction of a
secondary axis.
DISCUSSION
Results presented in this study demonstrate that the
Xenopus homologue of human Os4 can induce mesodermal
derivatives in Xenopus embryos. XOs4 was identified by its
ability to induce a secondary dorsal axis when injected into
the ventral marginal zone of Xenopus embryos. XOs4
s of reproduction in any form reserved.
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127Expression Cloning of Xenopus Os4transcripts were expressed in the preinvoluting mesoderm
in blastula- and gastrula-stage embryos, suggesting a role in
induction and/or patterning of this germ layer. Later in
development, XOs4 expression became enriched in the
dorsal neural tube and neural crest. The secondary axis-
inducing activity of XOs4 was distinct from other second-
ary axis-inducing pathways such as activation of the FGF or
Wnt pathways or inhibition of the BMP pathway, and was
similar, but not identical, to that of activation of the
Activin/Nodal/Vg1 pathway. For example, while XOs4 in-
duced expression of late mesodermal markers, XOs4 was
delayed in a weak induction of gastrula-stage markers for
mesoderm and XOs4 did not induce expression of organizer
markers. Moreover, epistatic analysis suggests that meso-
derm induction by XOs4 was partially independent of
transcriptional activation of the Activin/Nodal/Vg1 path-
way, since neither dominant-negative mutants of the Ac-
tivin receptor or FAST1 prevented induction of lateral
mesoderm by XOs4. Interestingly, like Activin-induced
mesoderm, XOs4 required FGF signaling for expression of
mesoderm markers in tadpole-stage animal cap explants.
Therefore, our results suggest that XOs4 induces a second-
ary dorsal axis by activating a mesoderm-inducing pathway
that, like the Activin/Nodal/Vg1 pathway, requires FGF
signaling for expression of mesoderm markers.
XOs4 and the Induction and Patterning of
Mesoderm
When overexpressed, XOs4 has the ability to induce
dorsal and lateral mesoderm in animal cap explants. In
addition, XOs4 is expressed in the preinvoluting mesoderm.
Taken together, these data suggest a possible role for XOs4
in induction of mesodermal derivatives. However, at gas-
trula stages, XOs4 transcripts are ubiquitously expressed
and we found no difference in the intracellular localization
of ectopic expression of FLAG-tagged XOs4 (a possible
indication of a change in activity) in dorsal vs. ventral
mesoderm. While this ubiquitous expression pattern of
XOs4 at gastrula stage does not immediately suggest a role
in mesoderm induction, like many ubiquitously expressed
signal-transducing molecules involved in mesoderm induc-
tion, the function of Os4 in mesoderm induction may be
regulated at multiple steps posttranscriptionally. For ex-
ample, transcripts for Smad2 are ubiquitously expressed,
but phosphorylation and nuclear localization regulate the
activity of Smad2 in the prospective mesoderm (Faure et al.,
2000). Alternatively, association with a temporally or spa-
tially localized protein may regulate XOs4 activity. For
example, XLdb1 is ubiquitously expressed at gastrula
stages, but association with the organizer-specific Xlim1
regulates its activity (Agulnick et al., 1996). While the
results presented in this study do not demonstrate a re-
quirement for XOs4 in mesoderm induction and patterning,
they do suggest the possible involvement of this gene
family in early patterning of the embryo. The demonstra-
tion of the requirement of XOs4 in the induction and/or
Copyright © 2001 by Academic Press. All rightatterning of endogenous mesoderm awaits further loss-of-
unction analysis.
Mechanism of Mesoderm and Secondary Axis
Induction by XOs4
In order to determine the mechanism of secondary axis
induction by XOs4, we compared the morphology of XOs4-
induced secondary axis to those induced by other pathways.
We concluded that it was unlikely that XOs4 induces a
secondary axis by activation of FGF pathways since FGF-
induced secondary axis consists of tail-like rather than
trunk-like structures. However, we have not completely
ruled out the possibility of XOs4 activating some FGF-
dependent pathways; in fact, we found that mesoderm
induction by XOs4 does required FGF signaling (see discus-
sion below). Furthermore, we determined that XOs4 does
not induce Nieuwkoop center-specific markers like Wnt
pathways nor does XOs4 inhibit BMP signaling. From these
observations, we concluded that XOs4 induces a secondary
axis similar to that induced by ectopic activation of
Activin/Nodal/Vg1 pathways.
Like activation of Activin/Nodal/Vg1 pathways, XOs4
induced mesoderm in tadpole-stage animal cap explants.
However, unlike Activin, XOs4 did not activate AREs nor
did XOs4 induce significant levels of organizer-specific
markers in gastrula-stage animal cap explants. Addition-
ally, XOs4 was substantially delayed in induction of
gastrula-stage mesodermal markers and was very weak in
its ability to induce expression of these markers. Further-
more, XOs4 induction of HoxB9 was independent of the
activity of the Activin receptor. In contrast, we found that
FAST1-EnR consistently reduced XOs4 induction of HoxB9
by approximately 50 percent. While this finding suggests
that XOs4 is still able to induce mesoderm when this
pathway is inhibited, this result does illustrate a partial
requirement for TGFb signaling via FAST1 in expression of
mesoderm markers in XOs4-expressing animal caps. This
does not reflect a general requirement for FAST1 in meso-
derm induction and/or maintenance, as FGF induction of
XBra was not blocked by an anti-FAST1 antibody, though
FAST-EnR was not tested (Watanabe and Whitman, 1999).
Furthermore, this inhibition could be a result of FAST1-
binding sites in a promoter acting upstream from HoxB9
transcription. If FAST1 is binding this promoter, associa-
tion with an Engrailed transcriptional repressor domain
could inhibit transcription from the promoter even if XOs4
is not activating this promoter via FAST1. Nevertheless,
these observations suggest that XOs4 is activating meso-
derm and secondary axis induction at least partially inde-
pendent of the Activin/Nodal/Vg1 pathway.
Another interesting observation was that XOs4 required
FGF signaling for expression of mesoderm markers. This
could indicate that XOs4 requires FGF for mesoderm induc-
tion and directly activates the pathway or alternatively,
XOs4, like Activin, requires FGF pathway for maintenance
of mesoderm (Cornell and Kimelman, 1994; LaBonne and
s of reproduction in any form reserved.
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128 Zohn and H. BrivanlouWhitman, 1994). We favor the latter alternative because of
the secondary axis phenotype induced by XOs4. While our
results do not exclude involvement of FGF pathways in
induction of mesoderm by XOs4, we find it unlikely that
XOs4 primarily activates FGF pathways to induce a second-
ary axis and mesoderm, since, morphologically, the second-
ary axis induced by XOs4 is distinct from FGF but identical
to that induced by Activin.
One interpretation of these combined observations is that
XOs4 is acting downstream of a mesoderm-inducing path-
way (such as the Activin pathway). For example, XBra can
induce mesoderm in animal cap explants, and expression of
XBra is induced by mesoderm-inducing pathways such as
Activin and FGF (reviewed in Smith, 2001), thus XBra acts
downstream of these mesoderm-inducing pathways. Con-
ceivably, XOs4 may interact with pathways downstream of
Xbra. The observation that XOs4 induces mesoderm later
than activation of the Activin pathway supports this type of
model. Furthermore, the observation that XOs4 requires
FIG. 6. XOs4 induces dorsal and lateral mesoderm in animal cap
xplants. (A) XOs4-expressing (1 ng) animal caps exhibit a partially
longated morphology indicated an inductive event. (a) Uninjected
nimal caps. (b) XOs4-injected animal caps at Stage 17. (B) XOs4-
xpressing animal caps express markers of posterior neural, neural
rest, and dorsal and lateral mesoderm. Embryos were injected at
he two-cell stage with the indicated RNAs. Animal caps explants
ere assayed by RT-PCR for expression of the indicated molecular
arkers at Stage 28.FGF signaling for expression of mesoderm at tadpole stages
Copyright © 2001 by Academic Press. All rightuggests that XOs4 may also require the same feedback
oops of other mesoderm-inducing pathways. Alternatively,
Os4 may be contributing to these feedback loops, which
ould explain the delayed and weak mesoderm-inducing
ctivity of XOs4. This model is purely speculative and
lucidation of the pathway that XOs4 utilizes for mesoderm
nduction awaits further characterization of XOs4 function.
or example, identification of XOs4-binding partners may
llow for a better understanding of the mechanism by
hich XOs4 induces mesoderm and secondary dorsal axes.
The Os4 Gene Family
XOs4 is a member of a large evolutionary conserved
family of proteins with members in all eukaryotes from
species as divergent as Dictyostelium, O. sativa (rice),
Arabidopsis, S. pombe, S. cerevisae, C. elegans, D. mela-
nogaster and H. sapiens. They share a conserved C-terminal
domain of approximately 200 amino acids and have little or
no sequence homology in their N-terminal domains. Most
family members have been identified through genome-
FIG. 7. XOs4 induces expression of mesoderm markers in animal
cap explants by late gastrula stages. (A) RNA encoding Smad2 (1 ng)
or XOs4 (1 ng) was injected into the animal pole region of two-cell
stage embryos. Animal cap explants expressing Smad2 or XOs4
were assayed by RT-PCR for expression of the indicated mesoderm
markers at early gastrula stage (10.5) (A) or late gastrula stage (12)
(B).
s of reproduction in any form reserved.
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the biological function of this gene family.
A distant relative, Fcp1 (the Xenopus homologue has 15%
overall sequence identity to XOs4), is a RNA Polymerase II
phosphatase (Kobor et al., 1999). Fcp1 phosphatase activity
is dependent on a novel DXDXT/V motif, which was
initially identified in a family of phosphotransferases and
phosphohydrolases (Collet et al., 1998; Kobor et al., 1999).
This motif is conserved throughout the Os4 family. The S.
cerevisiae Psr1p and Psr2p homologues contain the
DXDXT/V phosphatase motif and exhibit phosphatase ac-
tivity (Siniossoglou et al., 2000). Furthermore, mutation of
this motif to EXEXT/V results in a loss of ability to rescue
the mutant phenotype. Accordingly, mutation of the
DXDXT/V motif in XOs4 results in a loss of secondary
axis-inducing activity (I.Z. and A.H-B., unpublished obser-
vations), suggesting that the conserved phosphatase domain
may also be important for XOs4 function.
Nem1p is another more distantly related member of the
family that is required for proper nuclear membrane mor-
phology and sporulation in yeast (Siniossoglou et al., 1998).
FIG. 8. (A) XOs4 does not require activity of the Activin/Nodal/
Vg1 signal-transduction pathway upstream of FAST1 for induction
of mesodermal derivatives. Embryos were injected with RNA (1
ng/embryo) encoding either tAR or Fast-EnR in the absence or
presence of XOs4. Animal cap explants were dissected at blastula
stage, incubated in the presence or absence of Activin as indicated,
and cultured until control embryos reached tailbud stages (Stage
28). Animal cap explants were then processed for RT-PCR analysis
for expression of HoxB9, which is strongly induced by both Activin
and XOs4. (B) Like Smad2, XOs4 requires the FGF pathway for
expression of mesoderm markers at tadpole stages. Embryos were
injected with the indicated RNAs and animal cap explants were
assayed by RT-PCR for HoxB9 expression at tadpole stage. XFR (1.5
ng/embryo), dominant-inhibitiory Ras(17N), Smad2, and XOs4 (1
ng/embryo). Basic FGF (FGF) was added to a final concentration of
50 mg/ml.Studies with this protein suggest that not all Os4 homo-
Copyright © 2001 by Academic Press. All rightlogues have the same function. Other yeast Os4 homo-
logues could not rescue the nuclear envelope phenotype in
Nem1p cells, nor could fusion proteins of the conserved
Psr2p C-terminal domain with the N-terminal Nem1p
domain (Siniossoglou et al., 1998). However, this could be a
result of an altered cellular localization, as this fusion
protein was localized to the plasma membrane rather than
the nuclear membrane. Nem1p also contains the conserved
phosphatase motif; however, the requirement of this motif
for Nem1p activity and the ability of Nem1p to function as
a phosphatase have not yet been determined.
Role of hOs4 in Tumor Formation
XOs4 shares 79% sequence identity to hOs4. hOs4 is
localized to a region of chromosome 12q13–q15, which is
frequently amplified in human sarcomas and brain tumors
(Su et al., 1997). hOs4 was found to be amplified in a
number of tumors examined including pleomorphic sarco-
mas, malignant fibrous histocytomas, osteosarcomas, and
malignant Schwannomas. hOs4 was also amplified in tu-
mor cell lines including NGP-127 (neuroblastoma), OsA-Cl
(osteosarcoma), and RMS-13 (Rhabdomyosarcoma). This
region of amplification contains two core segments sepa-
rated by several megabases that can be amplified indepen-
dently, but are most often coamplified. The first region
contains MDM2 (a negative regulator of the tumor-
suppressor p53) and CHOP (a transcription factor). The
second region contains CDK4 (which promotes the G1 to S
transition in the cell cycle), SAS, Os9, and hOs4. Previ-
ously, the tumor-promoting effects of amplification of this
region of DNA were attributed to the activity of overex-
pression of CDK4 and MDM2; however, results from this
study suggest that Os4 may also contribute to tumor
formation by regulating cell fate in these tumors. Interest-
ingly, many of these tumors are derived from mesodermal
cells and the possibility of XOs4 regulating mesoderm cell
development further suggests a role in formation of these
tumors.
This study is the first report of an embryological function
for the large evolutionary conserved Os4 gene family. Two
members of this family are mutated in human tumors,
suggesting a role in human disease. Our data indicate that
XOs4 can regulate changes in cell fate during Xenopus
embryogenesis and may provide insight into the role of Os4
family members in human disease and normal cell func-
tion.
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